InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jeffrey William Henderson, Director, is a corporate insider tracked by InsiderTape across 4 companies. The public record shows 14 open-market SEC Form 4 transactions: 1 purchase worth $350K and 13 sales worth $2.9M, reported from Feb 22, 23 to Apr 28, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 28, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 4.3K | $61.00 | $259K |
| Apr 1, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 503 | $64.05 | $32K |
| Mar 3, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 3.2K | $59.12 | $189K |
| Feb 10, 25 | BDXBECTON DICKINSON & CO | BUY | 1.5K | $233.62 | $350K |
| Feb 3, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 3.9K | $56.41 | $220K |
| Jan 6, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 10.0K | $50.01 | $500K |
| Sep 1, 23 | FGENFIBROGEN INC | SELL | 2.0K | $1.03 | $2K |
| Aug 4, 23 | FGENFIBROGEN INC | SELL | 2.0K | $1.91 | $4K |
| Jul 11, 23 | FGENFIBROGEN INC | SELL | 2.0K | $2.69 | $5K |
| Jun 8, 23 | FGENFIBROGEN INC | SELL | 5.0K | $17.69 | $88K |
| Mar 1, 23 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 10.0K | $47.71 | $477K |
| Feb 28, 23 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 10.0K | $48.51 | $485K |
| Feb 23, 23 | QCOMQUALCOMM INC/DE | SELL | 2.5K | $124.19 | $310K |
| Feb 22, 23 | QCOMQUALCOMM INC/DE | SELL | 2.5K | $124.05 | $310K |